Charles Schumer on Drugs Democratic Sr Senator (NY)

Recognized as Guardian of a Drug-Free America

Voted NO on increasing penalties for drug offenses.

Rated B by NORML, indicating a pro-drug-reform stance.

OnTheIssues.org interprets the 2016 NORML scores as follows:

• C-/D/F: "hard-on-drugs" stance (approx. 243 members)
• C: mixed record on drug reform (approx. 45 members)
• A/B: pro-drug-reform stance (approx. 293 members)

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Require chemical resellers to certify against meth use.

Sen. FEINSTEIN: This act is designed to address problems that the Drug Enforcement Administration, DEA, has identified in the implementation of the Combat Methamphetamine Epidemic Act of 2005. The bill that I introduce today would:

• clarify that all retailers, including mail order retailers, who sell products that contain chemicals often used to make methamphetamine--like ephedrine, pseudoepedrine and phenylpropanolamine--must self-certify that they have trained their personnel and will comply with the Combat Meth Act's requirements;
• require distributors to sell these products only to retailers who have certified that they will comply with the law;
• require the DEA to publish the list of all retailers who have filed self-certifications, on the DEA's website;
• and clarify that any retailer who negligently fails to file self-certification as required, may be subject to civil fines and penalties.

This is a common-sense bill, designed to strengthen the implementation of the Combat Methamphetamine Epidemic Act. This bill would create incentives to ensure that the self-certification process of the law is made both effective and enforceable. I urge my colleagues to support this legislation.